Study title:
Experimentation du clorazepate dipotassique en psychiatrie infantile - Lacnay Cl.m Houzel D. - Rev. Neuropsychiatr. Infant., 1972, 20, (Mai), 491-495.Experimentation du clorazepate dipotassique en psychiatrie infantile - Lacnay Cl.m Houzel D. - Rev. Neuropsychiatr. Infant., 1972, 20, (Mai), 491-495.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Mental Disorders
|
Brands: |
MAH holders: |
Assessment: |
Active substance: POTASSIUM CLORAZEPATE |
ATC code: N05BA05 |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|